88358-11-6Relevant articles and documents
ADAMANTANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTION
-
Paragraph 0898-0899; 0904-0905, (2020/02/05)
Compounds of structural Formula I were developed for the treatment of infections by filoviruses including Ebolavirus and Marburgvirus, wherein, R1, R2, R3, X and Y are defined in the specification.
SPHINGOSINE KINASE INHIBITORS
-
Page/Page column 44, (2008/06/13)
The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.